Peddock Capital Advisors LLC Buys 735 Shares of CVS Health Co. (NYSE:CVS)

Peddock Capital Advisors LLC grew its position in CVS Health Co. (NYSE:CVS) by 3.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 22,506 shares of the pharmacy operator’s stock after purchasing an additional 735 shares during the period. Peddock Capital Advisors LLC’s holdings in CVS Health were worth $1,777,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently made changes to their positions in the company. SOA Wealth Advisors LLC. raised its holdings in shares of CVS Health by 4.9% in the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after purchasing an additional 133 shares during the period. Apella Capital LLC increased its holdings in CVS Health by 4.2% in the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after acquiring an additional 136 shares during the last quarter. Prairie Sky Financial Group LLC lifted its holdings in CVS Health by 4.1% during the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after purchasing an additional 141 shares during the last quarter. WealthShield Partners LLC boosted its position in CVS Health by 3.2% during the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock worth $355,000 after purchasing an additional 141 shares during the period. Finally, Sugarloaf Wealth Management LLC increased its stake in shares of CVS Health by 9.5% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 142 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS Health stock traded down $0.51 during trading on Wednesday, hitting $55.23. 8,199,387 shares of the stock traded hands, compared to its average volume of 11,829,027. The stock has a market cap of $69.33 billion, a price-to-earnings ratio of 9.71, a PEG ratio of 0.88 and a beta of 0.56. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. CVS Health Co. has a 52 week low of $53.70 and a 52 week high of $83.25. The firm’s fifty day moving average is $71.95 and its 200-day moving average is $73.09.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. CVS Health had a net margin of 2.03% and a return on equity of 13.53%. During the same quarter in the previous year, the business earned $2.20 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Research analysts expect that CVS Health Co. will post 7.03 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were given a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.82%. CVS Health’s payout ratio is 46.75%.

Insider Activity

In related news, Director Edward J. Ludwig purchased 1,000 shares of the firm’s stock in a transaction on Thursday, May 2nd. The shares were acquired at an average cost of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Edward J. Ludwig purchased 1,000 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the acquisition, the director now directly owns 21,630 shares in the company, valued at $1,165,424.40. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several analyst reports. Cantor Fitzgerald downgraded shares of CVS Health from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $87.00 to $58.00 in a report on Wednesday, May 1st. The Goldman Sachs Group dropped their price objective on CVS Health from $85.00 to $74.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. TD Cowen lowered CVS Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $99.00 to $59.00 in a report on Tuesday. Mizuho lowered their price target on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a report on Thursday, May 2nd. Finally, StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Nine equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $77.67.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.